vs
阿普塔集团（ATR）与罗致恒富（RHI）财务数据对比。点击上方公司名可切换其他公司
罗致恒富的季度营收约是阿普塔集团的1.4倍（$1.3B vs $962.7M），阿普塔集团同比增速更快（13.5% vs -5.8%），罗致恒富自由现金流更多（$170.8M vs $96.9M），过去两年阿普塔集团的营收复合增速更高（2.6% vs -6.1%）
阿普塔集团（AptarGroup, Inc.）是总部位于美国的全球性制造企业，主营消费品分配包装产品及药物给药装置的研发与生产，目前在全球18个国家设有生产运营基地，服务医药、快消等多领域客户。
罗致恒富是1948年成立的国际人力资源咨询机构，总部位于加利福尼亚州门洛帕克和圣拉蒙，是全球规模领先的会计与金融领域人才派遣服务商之一，在全球范围内设有超过345个办公点。
ATR vs RHI — 直观对比
营收规模更大
RHI
是对方的1.4倍
$962.7M
营收增速更快
ATR
高出19.3%
-5.8%
自由现金流更多
RHI
多$73.9M
$96.9M
两年增速更快
ATR
近两年复合增速
-6.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $962.7M | $1.3B |
| 净利润 | $74.3M | — |
| 毛利率 | — | 37.6% |
| 营业利润率 | 11.0% | 1.7% |
| 净利率 | 7.7% | — |
| 营收同比 | 13.5% | -5.8% |
| 净利润同比 | -26.4% | — |
| 每股收益（稀释后） | $1.13 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATRRHI
| Q4 25 | $962.7M | $1.3B | ||
| Q3 25 | $961.1M | $1.4B | ||
| Q2 25 | $966.0M | $1.4B | ||
| Q1 25 | $887.3M | $1.4B | ||
| Q4 24 | $848.1M | $1.4B | ||
| Q3 24 | $909.3M | $1.5B | ||
| Q2 24 | $910.1M | $1.5B | ||
| Q1 24 | $915.4M | $1.5B |
净利润ATRRHI
| Q4 25 | $74.3M | — | ||
| Q3 25 | $127.9M | $42.9M | ||
| Q2 25 | $111.7M | $41.0M | ||
| Q1 25 | $78.8M | $17.4M | ||
| Q4 24 | $100.9M | — | ||
| Q3 24 | $100.0M | $65.5M | ||
| Q2 24 | $90.5M | $68.2M | ||
| Q1 24 | $83.1M | $63.7M |
毛利率ATRRHI
| Q4 25 | — | 37.6% | ||
| Q3 25 | — | 37.2% | ||
| Q2 25 | — | 37.2% | ||
| Q1 25 | — | 36.9% | ||
| Q4 24 | — | 38.8% | ||
| Q3 24 | — | 39.0% | ||
| Q2 24 | — | 39.2% | ||
| Q1 24 | — | 38.1% |
营业利润率ATRRHI
| Q4 25 | 11.0% | 1.7% | ||
| Q3 25 | 14.2% | 1.0% | ||
| Q2 25 | 14.9% | 0.1% | ||
| Q1 25 | 12.8% | 2.9% | ||
| Q4 24 | 14.2% | 4.7% | ||
| Q3 24 | 15.2% | 4.1% | ||
| Q2 24 | 13.8% | 5.1% | ||
| Q1 24 | 12.2% | 2.8% |
净利率ATRRHI
| Q4 25 | 7.7% | — | ||
| Q3 25 | 13.3% | 3.2% | ||
| Q2 25 | 11.6% | 3.0% | ||
| Q1 25 | 8.9% | 1.3% | ||
| Q4 24 | 11.9% | — | ||
| Q3 24 | 11.0% | 4.5% | ||
| Q2 24 | 9.9% | 4.6% | ||
| Q1 24 | 9.1% | 4.3% |
每股收益（稀释后）ATRRHI
| Q4 25 | $1.13 | $0.32 | ||
| Q3 25 | $1.92 | $0.43 | ||
| Q2 25 | $1.67 | $0.41 | ||
| Q1 25 | $1.17 | $0.17 | ||
| Q4 24 | $1.48 | $0.53 | ||
| Q3 24 | $1.48 | $0.64 | ||
| Q2 24 | $1.34 | $0.66 | ||
| Q1 24 | $1.23 | $0.61 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $409.5M | $464.4M |
| 总债务越低越好 | $1.1B | — |
| 股东权益账面价值 | $2.7B | $1.3B |
| 总资产 | $5.3B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.43× | — |
8季度趋势，按日历期对齐
现金及短期投资ATRRHI
| Q4 25 | $409.5M | $464.4M | ||
| Q3 25 | $264.8M | $365.3M | ||
| Q2 25 | $169.8M | $380.5M | ||
| Q1 25 | $136.8M | $342.5M | ||
| Q4 24 | $226.2M | $537.6M | ||
| Q3 24 | $327.9M | $570.5M | ||
| Q2 24 | $223.9M | $547.4M | ||
| Q1 24 | $201.1M | $540.9M |
总债务ATRRHI
| Q4 25 | $1.1B | — | ||
| Q3 25 | $546.0M | — | ||
| Q2 25 | $535.1M | — | ||
| Q1 25 | $561.2M | — | ||
| Q4 24 | $688.1M | — | ||
| Q3 24 | $822.7M | — | ||
| Q2 24 | $681.5M | — | ||
| Q1 24 | $680.4M | — |
股东权益ATRRHI
| Q4 25 | $2.7B | $1.3B | ||
| Q3 25 | $2.8B | $1.3B | ||
| Q2 25 | $2.7B | $1.3B | ||
| Q1 25 | $2.5B | $1.3B | ||
| Q4 24 | $2.5B | $1.4B | ||
| Q3 24 | $2.5B | $1.5B | ||
| Q2 24 | $2.4B | $1.5B | ||
| Q1 24 | $2.3B | $1.5B |
总资产ATRRHI
| Q4 25 | $5.3B | $2.9B | ||
| Q3 25 | $5.1B | $2.8B | ||
| Q2 25 | $4.9B | $2.8B | ||
| Q1 25 | $4.5B | $2.7B | ||
| Q4 24 | $4.4B | $2.9B | ||
| Q3 24 | $4.6B | $3.0B | ||
| Q2 24 | $4.5B | $2.9B | ||
| Q1 24 | $4.4B | $2.9B |
负债/权益比ATRRHI
| Q4 25 | 0.43× | — | ||
| Q3 25 | 0.20× | — | ||
| Q2 25 | 0.20× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 0.32× | — | ||
| Q2 24 | 0.28× | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $183.7M | $182.5M |
| 自由现金流经营现金流 - 资本支出 | $96.9M | $170.8M |
| 自由现金流率自由现金流/营收 | 10.1% | 13.1% |
| 资本支出强度资本支出/营收 | 9.0% | 0.9% |
| 现金转化率经营现金流/净利润 | 2.47× | — |
| 过去12个月自由现金流最近4个季度 | $299.6M | $266.8M |
8季度趋势，按日历期对齐
经营现金流ATRRHI
| Q4 25 | $183.7M | $182.5M | ||
| Q3 25 | $177.6M | $77.4M | ||
| Q2 25 | $126.0M | $119.4M | ||
| Q1 25 | $82.7M | $-59.3M | ||
| Q4 24 | $178.2M | $154.8M | ||
| Q3 24 | $229.3M | $129.6M | ||
| Q2 24 | $143.6M | $142.0M | ||
| Q1 24 | $92.3M | $-15.9M |
自由现金流ATRRHI
| Q4 25 | $96.9M | $170.8M | ||
| Q3 25 | $114.3M | $63.6M | ||
| Q2 25 | $62.5M | $104.2M | ||
| Q1 25 | $25.9M | $-71.7M | ||
| Q4 24 | $112.2M | $140.5M | ||
| Q3 24 | $162.7M | $111.8M | ||
| Q2 24 | $75.4M | $129.6M | ||
| Q1 24 | $16.7M | $-27.7M |
自由现金流率ATRRHI
| Q4 25 | 10.1% | 13.1% | ||
| Q3 25 | 11.9% | 4.7% | ||
| Q2 25 | 6.5% | 7.6% | ||
| Q1 25 | 2.9% | -5.3% | ||
| Q4 24 | 13.2% | 10.2% | ||
| Q3 24 | 17.9% | 7.6% | ||
| Q2 24 | 8.3% | 8.8% | ||
| Q1 24 | 1.8% | -1.9% |
资本支出强度ATRRHI
| Q4 25 | 9.0% | 0.9% | ||
| Q3 25 | 6.6% | 1.0% | ||
| Q2 25 | 6.6% | 1.1% | ||
| Q1 25 | 6.4% | 0.9% | ||
| Q4 24 | 7.8% | 1.0% | ||
| Q3 24 | 7.3% | 1.2% | ||
| Q2 24 | 7.5% | 0.8% | ||
| Q1 24 | 8.3% | 0.8% |
现金转化率ATRRHI
| Q4 25 | 2.47× | — | ||
| Q3 25 | 1.39× | 1.80× | ||
| Q2 25 | 1.13× | 2.91× | ||
| Q1 25 | 1.05× | -3.42× | ||
| Q4 24 | 1.77× | — | ||
| Q3 24 | 2.29× | 1.98× | ||
| Q2 24 | 1.59× | 2.08× | ||
| Q1 24 | 1.11× | -0.25× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
RHI
| Finance And Accounting | $535.2M | 41% |
| Protiviti | $479.0M | 37% |
| Technology | $156.4M | 12% |
| Permanent Placement Talent Solutions | $102.6M | 8% |
| Other | $29.2M | 2% |
